首页> 外文期刊>Journal of nanoscience and nanotechnology >Preparation of Dipyridamole/Polyurethane Core-Shell Nanofibers by Coaxial Electrospinning for Controlled-Release Antiplatelet Application
【24h】

Preparation of Dipyridamole/Polyurethane Core-Shell Nanofibers by Coaxial Electrospinning for Controlled-Release Antiplatelet Application

机译:同轴静电纺丝法制备双嘧达莫/聚氨酯核壳纳米纤维

获取原文
获取原文并翻译 | 示例
           

摘要

To improve the hemocompatibility of blood-compatiblematerials, antiplatelet drug dipyridamole (DIP) was encapsulated in polyurethane (PU) to form core-shell nanofibers by coaxial electrospinning method. PU solution and DIP/polycaprolactone compound solution served as shell and core fluid, respectively. Uniform fibers without beads, were fabricated and a clear core-shell structure was generated. The diameter of nanofibers and core structure increased with an increase in the flow rate of the core solution. X-Ray diffraction and differential scanning calorimeter showed that the whole system formed solid dispersion and DIP was dispersed in polymer matrix in an amorphous state. In vitro drug release test demonstrated that releasing curve had two phases consisting of initial burst release and sustained release governed by diffusion mechanism. A more flat curve occurred when the diameter of PU shell increased. In this case, the PU shell served as a barrier restricted DIP release from core drug reservoir. In vitro platelet adhesion test demonstrated that the DIP had maintained its antiplatelet effect after coaxial electrospinning process and could present distinguished antiplatelet activity after 7th and 30th days. Finally, DIP loaded core-shell nanofiber mats with good hemocompatibility, were conveniently fabricated by coaxial electrospinning, which has great potential in the field of tissue engineering vascular graft.
机译:为了提高血液相容性材料的血液相容性,将抗血小板药双嘧达莫(DIP)包裹在聚氨酯(PU)中,通过同轴电纺丝法形成核-壳纳米纤维。 PU溶液和DIP /聚己内酯化合物溶液分别用作壳液和岩心液。制备了没有珠粒的均匀纤维,并生成了透明的核-壳结构。纳米纤维的直径和核心结构随着核心溶液流速的增加而增加。 X射线衍射和差示扫描量热仪显示,整个系统形成固体分散体,并且DIP以无定形状态分散在聚合物基质中。体外药物释放试验表明,释放曲线具有初始爆发释放和持续释放两个阶段,受扩散机制控制。当PU壳的直径增加时,出现更平坦的曲线。在这种情况下,PU壳用作从核心药物储库释放DIP的屏障。体外血小板粘附试验表明,DIP在同轴静电纺丝后仍保持其抗血小板作用,并在第7天和第30天表现出明显的抗血小板活性。最后,通过同轴静电纺丝方便地制备了DIP负载的具有良好血液相容性的核-壳纳米纤维垫,在组织工程血管移植领域具有巨大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号